A Randomized Controlled Phase II Clinical Trial of Reconstruction method for the Elderly patients with gastric cancer after Distal Gastrectomy; Billroth-II Versus Roux-en-Y reconstruction - A Randomized Controlled Phase II Clinical Trial of Reconstruction method for the Elderly patients with gastric cancer after Distal Gastrectomy; Billroth-II Versus Roux-en-Y reconstruction

Clinical Study Group of Osaka University0 个研究点目标入组 100 人开始时间: 2022年3月1日最近更新: 2023年10月17日

研究概览

暂无简介。

•2-1) Patients with non-curative factors such as peritoneal dissemination, liver metastasis, distant metastasis, or invasion of other organs (T4b) in pre-treatment and preoperative examinations (abdominal CT, abdominal ultrasound, x-ray, etc., in addition to general blood tests). 2-2) Patients with concurrent multiple cancers other than stomach. However, carcinoma in situ of cervical cancer and focal cancer in adenoma of colorectal cancer are not exclusion criteria. 2-3) Patients with heterogeneous multiple cancers that have recurred after treatment or have not passed more than 5 years after treatment. (2-3) Heterogeneous multiple cancers that have recurred after treatment or have not been treated for more than 5 years. 2-4) Patients with emphysema, etc. 2-4) Patients with severe respiratory disorders such as emphysema. 2-5) Patients with a definite history of myocardial infarction. Or cases that can be judged positive by Master two step. 2-6) Cirrhosis or 2-6) Patients with liver cirrhosis or active hepatitis. 2-7) Patients with chronic renal failure requiring dialysis. 2-7) Patients with chronic renal failure requiring dialysis. 2-8) Diabetic patients with poor control (HbA1c: 8.0 or higher). (2-9) Patients who are judged by the investigator to be inappropriate for the safe conduct of the study. 2-10) Patients with reflux esophagitis (LA classification A or higher).

发起方

Clinical Study Group of Osaka University